ARGS - .41 Pre-market now at .50/.51 Argos Provides Update on its ADAPT Trial Following Meeting with FDA http://stockcharts.com/c-sc/sc?s=ARGS&p=D&b=5&g=0&i=t31692432129&r=1494420316937 http://stockcharts.com/c-sc/sc?s=ARGS&p=W&b=5&g=0&i=t80931005563&r=1494420280770